Interest: NeurOp, Inc., a biopharmaceutical company developing new treatments for central nervous system disorders, today announced that it is one of 40 companies selected to participate in the 2011-2012 Commercialization Assistance Program (CAP) funded by the National Institutes of Health (NIH) and managed and executed by the Larta Institute.
Interest: Researchers at Northwestern University have created a hybrid nanomaterial consisting of electrically conductive particles coated with a positively charged chemical and surrounded by negatively charged atoms.
Interest: A new technology from the University of Minnesota has resulted in a startup that may help prolong the lives of victims suffering from massive blood loss or trauma.
Interest: ornell will partner with The Technion – Israel Institute of Technology in its bid to win New York City’s competition for a new applied science and engineering campus, the University announced Tuesday.
Interest: With recorded success developing a self-learning robot, a UA team of researchers is working under a five-year, $3 million grant to improve what the robot is teaching itself.
Interest: After a daylong hearing in a packed House Chamber at Legislative Hall, the Public Service Commission (PSC) unanimously approved a deal that paves the way to bring fuel cell technology to Delaware.
Interest: In early September, U.S. President Barack Obama withdrew an EPA air-quality standard for Big Oil and the manufacturing industry that was meant to reduce ground-level ozone down from 75 parts per billion to between 60 and 70 parts per billion.
Interest: Georgia Tech, Children’s Healthcare of Atlanta, Emory University and Saint Joseph’s Translational Research Institute have received a $1.8 million grant to develop medical devices focused on the special needs of children.
Interest: BioTime, Inc. BTX +2.02% announced today the publication in the peer-reviewed journal Stem Cell Research of the complete genome sequence analysis of five clinical-grade human embryonic stem cell lines. "Evaluating the Genomic and Sequence Integrity of Human ES Cell Lines
Interest: QR Pharma, Inc. (QR), a clinical-stage specialty pharmaceutical company committed to developing therapeutics with novel approaches for the treatment of cognitive impairment and Alzheimer's disease (AD), along with the Medical University of South Carolina (MUSC) report on the results obtained from the Small Business Innovation Research (SBIR) phase I grant study on Posiphen(R).
Interest: Tacoma now has an Urban Clean Water Technology Innovation Partnership Zone (IPZ) designed to link university research with the business community and lead to the creation of new companies and new jobs for Tacoma-Pierce County.
Interest: Interdisciplinary collaborations bring vitality and success to the nation's research enterprise. Such interactions among disciplines also provide robust, real-life experiences for university students.
Interest: Oregon Health & Science University,Portland State University and Oregon State University united to develop the aptly-named Collaborative Life Sciences Building, 2750 S.W. Moody Ave. It will contain a mix of teaching facilities, laboratories, offices and retail space.
Interest: Senior Scientific, LLC, founded by Edward R. Flynn, Ph.D., and currently funded by its public parent company, Manhattan Scientifics, is preparing to commercialize its nano-electromagnetic sensing technology, in collaboration with several leading cancer research hospitals in the U.S.
Interest: Researchers have created artificial muscles that can twist 1,000 times more than any suitable material made in the past—a development that could prove useful in robots and prosthetic limbs.
Interest: University of Utah undergraduate Ryan Robinson has won a national nanotechnology competition for his project developing ultra-tiny “cages” for delivering anti-cancer drugs.
Interest: Cheektowaga research institution CUBRC has won a five-year contract that could be worth up to $36 million over five years from the National Institutes of Health.
My profile
Loading...